Organon (OGN) Non-Current Debt (2021 - 2026)
Organon (OGN) posted Non-Current Debt of $8.6 billion for Q2 2026, little changed on a QoQ basis from $8.6 billion in Q1 2026, and down 3.86% year-over-year from $8.9 billion in Q2 2025.
Analysis
Organon (OGN) Non-Current Debt (2021 - 2026) Analysis & Trends
Organon has reported Non-Current Debt for 6 years, with the latest figure at $8.6 billion in Q2 2026.
- On a quarterly basis, Non-Current Debt fell 3.86% year-over-year to $8.6 billion in Q2 2026; TTM through Jun 2026 was $8.6 billion, a 3.86% decrease from a year earlier, with the FY2025 full-year figure at $8.6 billion, down 2.66% from the prior year.
- Non-Current Debt was $8.6 billion for Q2 2026 at Organon, roughly flat from $8.6 billion in the prior quarter.
- The five-year high for Non-Current Debt was $9.1 billion in Q1 2022, with the low at $8.6 billion in Q2 2026.
- Average Non-Current Debt over 5 years is $8.8 billion, with a median of $8.7 billion recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Non-Current Debt fell 6.46% in 2022, then increased 2.78% in 2025.
- Over 5 years, Non-Current Debt stood at $8.9 billion in 2022, then fell by 1.82% to $8.8 billion in 2023, then grew by 1.47% to $8.9 billion in 2024, then fell by 2.66% to $8.6 billion in 2025, then dropped by 1.05% to $8.6 billion in 2026.
- The last three Non-Current Debt figures came in at $8.6 billion (Q2 2026), $8.6 billion (Q1 2026), and $8.6 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 60.50 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 17.02 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | - |
| 10 | Organon | 3.58 Bn | 2.45 Bn | 847.00 Mn | 8.55 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.55 Bn |
| Mar 31, 2026 | 8.57 Bn |
| Dec 31, 2025 | 8.64 Bn |
| Sep 30, 2025 | 8.83 Bn |
| Jun 30, 2025 | 8.90 Bn |
| Mar 31, 2025 | 8.96 Bn |
| Dec 31, 2024 | 8.88 Bn |
| Sep 30, 2024 | 8.75 Bn |
| Jun 30, 2024 | 8.66 Bn |
| Mar 31, 2024 | 8.71 Bn |
| Dec 31, 2023 | 8.75 Bn |
| Sep 30, 2023 | 8.65 Bn |
| Jun 30, 2023 | 8.73 Bn |
| Mar 31, 2023 | 8.71 Bn |
| Dec 31, 2022 | 8.91 Bn |
| Sep 30, 2022 | 8.70 Bn |
| Jun 30, 2022 | 8.90 Bn |
| Mar 31, 2022 | 9.10 Bn |
| Dec 31, 2021 | 9.13 Bn |
| Sep 30, 2021 | 9.30 Bn |